GSK, Xenoport cleared for Restless Legs Syndrome drug
GlaxoSmithKline (GSK) and XenoPort Inc. have received approved from the Food and Drug Administration for Horizant Extended-Release Tablets, a treatment for moderate-to-severe primary Restless Legs Syndrome in adults.